ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,981Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 384

$828K Total Retail Price of All Prescriptions

Rank: 12 out of 384

652 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 652 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 13,616 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,457 1,119 1 1
METFORMIN HCL 798 532 2 2
LOSARTAN-HYDROCHLOROTHIAZIDE 699 424 3 10
SYNTHROID 691 532 4 9
GABAPENTIN 643 432 5 4
LOSARTAN POTASSIUM 597 432 6 5
RANITIDINE HCL 487 313 7 7
AMLODIPINE BESYLATE 462 373 8 3
LEVOTHYROXINE SODIUM 446 357 9 11
ATENOLOL 396 265 10 12
TRAMADOL HCL-ACETAMINOPHEN 324 221 11 13
METOPROLOL TARTRATE 322 264 12 15
OMEPRAZOLE 322 217 12 8
ALENDRONATE SODIUM 310 234 14 20
LISINOPRIL 293 194 15 14
HUMULIN N 279 204 16 57
GLIMEPIRIDE 275 194 17 18
PLAVIX 271 214 18 32
DIOVAN HCT 264 223 19 66
CARVEDILOL 262 202 20 23
CLOPIDOGREL 242 196 21 30
CLOTRIMAZOLE-BETAMETHASONE 226 133 22 58
HYDROCHLOROTHIAZIDE 206 166 23 16
DICLOFENAC POTASSIUM 201 140 24 38
ENALAPRIL MALEATE 187 138 25 6
LANTUS 180 125 26 42
ISOSORBIDE MONONITRATE ER 173 148 27 28
NABUMETONE 172 107 28 34
FAMOTIDINE 170 131 29 35
FUROSEMIDE 169 138 30 17
ZOLPIDEM TARTRATE 161 107 31 19
GLIPIZIDE-METFORMIN 161 108 10 31 258
DONEPEZIL HCL 157 150 33 33
DIOVAN 150 110 34 54
DOXAZOSIN MESYLATE 149 131 35 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 122 36 78
GLIPIZIDE 139 109 37 27
SULINDAC 129 73 38 79
DIGOXIN 112 101 39 49
PANTOPRAZOLE SODIUM 108 60 40 39
SERTRALINE HCL 107 101 41 26
BENAZEPRIL HCL 106 75 42 204
VERAPAMIL ER 106 90 42 41
NAMENDA 105 104 44 67
GLIPIZIDE ER 104 78 45 105
TAMSULOSIN HCL 102 87 46 25
INSULIN SYRINGE 101 63 47 46
METOPROLOL SUCCINATE 99 70 48 21
IRBESARTAN 93 54 49 55
CIPROFLOXACIN HCL 92 60 50 50
DEXAMETHASONE 90 51 51 117
COUMADIN 90 76 51 100
ATORVASTATIN CALCIUM 89 64 53 22
AMLODIPINE BESYLATE-BENAZEPRIL 85 73 54 43
DOXYCYCLINE HYCLATE 85 62 54 216
GLIPIZIDE XL 83 78 56 115
DICLOFENAC SODIUM 81 38 57 81
AVAPRO 79 67 58 87
SINGULAIR 78 64 59 63
WARFARIN SODIUM 74 67 60 48
ORPHENADRINE CITRATE 74 24 R 60 124
IBANDRONATE SODIUM 69 50 62 219
NAPROXEN SODIUM 68 27 63 164
KETOCONAZOLE 68 42 63 142
HUMALOG MIX 75-25 64 62 65 104
AVELOX 62 38 66 249
TRICOR 60 37 67 123
JANUMET 58 38 68 116
AZITHROMYCIN 54 37 69 59
PREDNISONE 54 36 69 56
METOLAZONE 52 46 71 222
CLOBETASOL PROPIONATE 52 22 71 165
ACTOS 51 46 73 169
GEMFIBROZIL 51 33 73 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.